The historical rank and industry rank for Evolutionary Genomics's Net Margin % or its related term are showing as below:
FNAM's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -151.78 * Ranked among companies with meaningful Net Margin % only.
Evolutionary Genomics Net Margin % Historical Data
The historical data trend for Evolutionary Genomics's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Evolutionary Genomics's Net Margin %
For the Biotechnology subindustry, Evolutionary Genomics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolutionary Genomics's Net Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Evolutionary Genomics's Net Margin % distribution charts can be found below:
* The bar in red indicates where Evolutionary Genomics's Net Margin % falls into.
Evolutionary Genomics Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Evolutionary Genomics's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolutionary Genomics (OTCPK:FNAM) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Evolutionary Genomics Net Margin % Related Terms
Thank you for viewing the detailed overview of Evolutionary Genomics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Evolutionary Genomics (Evolutionary Genomics) Business Description
Evolutionary Genomics Inc is involved in the development of a technology platform, the Adapted Traits Platform (ATP), to identify commercially valuable genes that control important traits in animals and plants. It uses the ATP to identify genes to improve crop plant traits such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. The company's platform identifies key genes that have changed successfully to impart new or improved traits. Its primary source of revenue had been contract services revenue for research performed by it on behalf of other commercial entities and grant income received from governmental agencies, industry associations and grant-making foundations for research performed.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FNAM has been successfully added to your 